- About Us
- Clinical Trials
- News & Publications
- Business Development
Leukapheresis product is starting material for every single production of autologous vaccine in SOTIO DCVAC programs.
Leukapheresis is a clinical procedure in which white blood cells are separated from patient’s blood. It is a specific type of apheresis, in general it means separating out of one particular constituent of blood and returning the remaining blood components back to the circulation.
SOTIO is responsible not only for successful cells collection, but also for safe transport to SOTIO laboratories within 30 hrs from start of Leukapheresis.
SOTIO collaborates with more than 130 Apheresis Centres in Europe and US region. All cooperating centres are certified by related national regulatory institutions and regularly audited by SOTIO.